Comparative Evaluation of CHROMagar and Conventional Carbohydrate Fermentation Test for Candida Species Identification in HIV Patients: Assessing Sensitivity and Specificity
DOI:
https://doi.org/10.52783/jns.v14.3345Keywords:
Oral Candida, CHROMagar, HIV, Sensitivity, SpecificityAbstract
Context: Candida species are opportunistic fungal pathogens commonly associated with infections in immunocompromised individuals, particularly those with HIV. Reliable identification of Candida species is crucial for appropriately treating and managing these infections. The Conventional Carbohydrate fermentation test, traditionally used for species identification, has limitations, so alternative methods like CHROMagar, a chromogenic culture medium, are being explored. CHROMagar offers faster results and easier interpretation, making it a promising alternative.
Aims: The present study aims to isolate and speciate different candida species among HIV-positive patients by the CHROMagar method and Carbohydrate fermentation test and to determine the sensitivity and specificity of both methods.
Methods and Material: Oral rinse was collected from each subject in sterile sample containers and speciation was done by CHROMagar method and carbohydrate fermentation test.
Results: The sensitivity and specificity of the CHROMagar method in the present study were 100% and 45% respectively, whereas the sensitivity and specificity of the carbohydrate fermentation test were 63% and 25% respectively showing that the CHROMagar method is more accurate with 80% accuracy when compared to carbohydrate fermentation test with 53% accuracy.
Conclusions: CHROMagar provides fast and accurate identification of Candida species compared to conventional carbohydrate fermentation tests. This method's potential application in HIV patients to identify specific species and assess their immune status is important for treating infections and understanding the incidence and role of Candida species in invasive and systemic diseases.
Downloads
Metrics
References
Silva S, Pires P, Monteiro DR, Negri M, Gorup LF, Camargo ER, et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. Med Mycol. 2013 Feb;51(2):178-84. doi: 10.3109/13693786.2012.700492. Epub 2012 Jul 17. PMID: 22803822.
Sajjan D, Mahalakshmi D, Hajare VD. Prevalence and Antifungal Susceptibility of Candida Species Isolated From Patients Attending Tertiary Care Hospital. IOSR J Dent Med Sci. 2014;13:44-49. DOI: 10.9790/0853-13524449.
Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans-The Virulence Factors and Clinical Manifestations of Infection. J Fungi (Basel). 2021 Jan 22;7(2):79. doi: 10.3390/jof7020079. PMID: 33499276; PMCID: PMC7912069.
Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br Dent J. 2017 Nov 10;223(9):675-681. doi: 10.1038/sj.bdj.2017.886. PMID: 29123282.
Suryana K, Suharsono H, Antara IGPJ. Factors Associated with Oral Candidiasis in People Living with HIV/AIDS: A Case Control Study. HIV AIDS (Auckl). 2020 Jan 14;12:33-39. doi: 10.2147/HIV.S236304. PMID: 32021484; PMCID: PMC6969700.
Taylor M, Brizuela M, Raja A. Oral Candidiasis. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545282/
Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994 Aug;32(8):1923-9. doi: 10.1128/jcm.32.8.1923-1929.1994. PMID: 7989544; PMCID: PMC263904
Baradkar VP, Mathur M, Kumar S. Hichrom candida agar for identification of Candida species. Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):93-5. doi: 10.4103/0377-4929.59192. PMID: 20090231.
Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, et al. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Rev Iberoam Micol. 2005 Jun;22(2):83-92. doi: 10.1016/s1130-1406(05)70014-0. PMID: 16107165.
Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryot Cell. 2008 Jul;7(7):1075-84. doi: 10.1128/EC.00062-08. Epub 2008 May 2. PMID: 18456859; PMCID: PMC2446668.
Banu, Asima & Khan, Khadeer & Mansa, S. & Krishnam, Sanjith. (2015). Study of Candida Colonization and Speciation in HIV-Positive Patients in a Tertiary Care Hospital. International Journal of Current Research. 12935-12939.
Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother. 1995 Nov;39(11):2378-86. doi: 10.1128/AAC.39.11.2378. PMID: 8585712; PMCID: PMC162951.
Deorukhkar SC, Saini S. Laboratory approach for diagnosis of candidiasis through ages. 2014.
de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev. 2004 Oct;17(4):729-59, table of contents. doi: 10.1128/CMR.17.4.729-759.2004. PMID: 15489345; PMCID: PMC523562.
Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Groß U, Mshana SE. High oral carriage of non-albicans Candida spp. among HIV-infected individuals. International Journal of Infectious Diseases. 2016 Aug 1;49:185-8.
Quindós G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, et al. Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019 Mar 1;24(2):e172-e180. doi: 10.4317/medoral.22978. PMID: 30818309; PMCID: PMC6441600.
Unknown author. External factors influencing candidal identification: Impact of antifungal resistance. [Internet]. Mountain View, CA: Google; [Year unknown] [cited 2025 Feb 02]. Available from: https://www.google.com/antifungal-resistance-candida
Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, et al. Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis. 2013 Feb 12;13:82. doi: 10.1186/1471-2334-13-82. PMID: 23398783; PMCID: PMC3577436.
Moges B, Bitew A, Shewaamare A. Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis. Int J Microbiol. 2016;2016:3037817. doi: 10.1155/2016/3037817. Epub 2016 Jan 5. PMID: 26880925; PMCID: PMC4736391.
Goulart LS, Souza WWR, Vieira CA, Lima JS, Olinda RA, Araújo C. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study. Einstein (Sao Paulo). 2018 Aug 6;16(3):eAO4224. doi: 10.1590/S1679-45082018AO4224. PMID: 30088546; PMCID: PMC6080703.
Aboualigalehdari E, Tahmasebi Birgani M, Fatahinia M, Hosseinzadeh M. Oral colonization by Candida species and associated factors in HIV-infected patients in Ahvaz, southwest Iran. Epidemiol Health. 2020;42:e2020033. doi: 10.4178/epih.e2020033. Epub 2020 May 24. PMID: 32512666; PMCID: PMC7644944.
Kali, A & Sreenivasan, Srirangaraj & Charles, Pmv. (2015). A cost-effective carbohydrate fermentation test for yeast using microtitre plate. Indian journal of medical microbiology. 33. 293-5. 10.4103/0255-0857.154884.
Giri, Sidhartha & Kindo, Anupma. (2015). Evaluation of Five Phenotypic Tests in the Identification of Candida Species. National Journal of Laboratory Medicine. 4. 13-18. 10.7860/NJLM/2015/13492:2057.
Pravin Charles MV, Kali A, Joseph NM. Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials. Pharmacognosy Res. 2015 Jun;7(Suppl 1):S69-73. doi: 10.4103/0974-8490.150528. PMID: 26109791; PMCID: PMC4466772.
Nayak S, Kavitha B, Sriram G, Saraswathi TR, Sivapathasundharam B, Dorothy AL. Comparative study of Candida by conventional and CHROMagar method in non-denture and denture wearers by oral rinse technique. Indian J Dent Res. 2012 Jul-Aug;23(4):490-7. doi: 10.4103/0970-9290.104956. PMID: 23257483.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.